Provided by Tiger Trade Technology Pte. Ltd.

TJ DaRenTang USD

2.600
+0.0501.96%
Volume:77.10K
Turnover:198.36K
Market Cap:2.00B
PE:15.82
High:2.610
Open:2.550
Low:2.540
Close:2.550
52wk High:3.319
52wk Low:1.959
Shares:770.00M
Float Shares:421.34M
Volume Ratio:0.65
T/O Rate:0.02%
Dividend:0.71
Dividend Rate:27.41%
EPS(TTM):0.164
EPS(LYR):0.412
ROE:11.28%
ROA:5.13%
PB:2.27
PE(LYR):6.31

Loading ...

Tianjin Pharmaceutical Da Ren Tang Group to Host Online Briefing on Interim Results

SGX Filings
·
Yesterday

Tianjin Pharmaceutical Da Ren Tang reports status of placement proceeds and project changes

SGX Filings
·
Aug 14

Tianjin Pharmaceutical Da Ren Tang Proposes Amendments to Articles of Association

SGX Filings
·
Aug 14

Tianjin Pharmaceutical Da Ren Tang releases H1 2026 risk assessment on in-house finance arm

SGX Filings
·
Aug 14

Tianjin Pharmaceutical Unit Gets China's Nod for Diabetes Drug Registration

MT Newswires
·
Aug 10

Tianjin Pharmaceutical Da Ren Tang to Sign Warehousing Deal

MT Newswires
·
Aug 10

Tianjin Pharmaceutical Da Ren Tang receives Chinese approval for diabetes combo tablets

SGX Filings
·
Aug 07

Tianjin Pharmaceutical Da Ren Tang to Ink S$3.6 Million Related-Party Logistics Deal

SGX Filings
·
Aug 07

Tianjin Pharmaceutical Da Ren Tang Group’s Parent Lifts Stake to 43.09%

SGX Filings
·
Aug 04

Tianjin Pharmaceutical Da Ren Tang Group Issues July Update on Subsidiary Bankruptcy

SGX Filings
·
Jul 31

Tianjin Pharmaceuticals Warns of Up to 68% Plunge in H1 Profit

MT Newswires Live
·
Jul 14

Tianjin Pharmaceutical Da Ren Tang projects steep profit fall for 1H FY2026

SGX Filings
·
Jul 14

Tianjin Pharmaceutical Da Ren Tang updates on subsidiary’s bankruptcy liquidation

SGX Filings
·
Jun 30

Tianjin Pharmaceutical Da Ren Tang Group Approves FY2025 Reports, Profit Distribution and IPT Mandates at AGM

SGX Filings
·
Jun 03

Tianjin Pharmaceutical Da Ren Tang Sets Jun, 10 2026 Online Briefing for FY2025 and Q1 2026 Results

SGX Filings
·
Jun 02

Chinese State-Backed Entities to Dispose of Stake in Tianjin Pharmaceutical Da Ren Tang Unit via Public Tender

MT Newswires
·
May 20

Tianjin Pharmaceutical Da Ren Tang Group Notes Planned Sale of Upstream Shareholder

SGX Filings
·
May 19

Tianjin Pharmaceutical Da Ren Tang Group issues April update on subsidiary’s bankruptcy

SGX Filings
·
Apr 30

Singapore Shares Surge More Than 1% as DBS Books Record Total Income

MT Newswires
·
Apr 30

Tianjin Pharmaceuticals Da Ren Tang's Attributable Profit Jumps 13% in Q1; Shares Up 5%

MT Newswires
·
Apr 30